» Articles » PMID: 32844416

Current Understanding of Periodontal Disease Pathogenesis and Targets for Host-modulation Therapy

Overview
Date 2020 Aug 27
PMID 32844416
Citations 151
Authors
Affiliations
Soon will be listed here.
Abstract

Recent advances indicate that periodontitis is driven by reciprocally reinforced interactions between a dysbiotic microbiome and dysregulated inflammation. Inflammation is not only a consequence of dysbiosis but, via mediating tissue dysfunction and damage, fuels further growth of selectively dysbiotic communities of bacteria (inflammophiles), thereby generating a self-sustained feed-forward loop that perpetuates the disease. These considerations provide a strong rationale for developing adjunctive host-modulation therapies for the treatment of periodontitis. Such host-modulation approaches aim to inhibit harmful inflammation and promote its resolution or to interfere directly with downstream effectors of connective tissue and bone destruction. This paper reviews diverse strategies targeted to modulate the host periodontal response and discusses their mechanisms of action, perceived safety, and potential for clinical application.

Citing Articles

Proanthocyanidin B2 alleviates LPS-induced RAW264.7 cellular inflammation and oxidative stress via PI3K/Akt/NFkB pathway.

Ou X, Chen X, Fang Z, Zhao J Cytotechnology. 2025; 77(2):77.

PMID: 40078375 PMC: 11893968. DOI: 10.1007/s10616-025-00734-6.


Investigation of the relationship between apical periodontitis and host modulation provided by nutritional supplement: a study in rats.

Cankaya G, Ocak M, Dundar S, Ozercan I BMC Oral Health. 2025; 25(1):336.

PMID: 40038698 PMC: 11881480. DOI: 10.1186/s12903-025-05705-z.


Finite element stress analysis to evaluate and compare the effect of splinting in periodontally compromised teeth having 55 % bone loss with different materials.

Joshi S, Talreja P, Rao P, Joshi N, Thorat V, Mohta R J Oral Biol Craniofac Res. 2025; 15(2):250-255.

PMID: 40027851 PMC: 11869020. DOI: 10.1016/j.jobcr.2025.01.011.


Inflammation-triggered Gli1 stem cells engage with extracellular vesicles to prime aberrant neutrophils to exacerbate periodontal immunopathology.

Cai X, Zheng C, Guo H, Fan S, Huang X, Chen J Cell Mol Immunol. 2025; .

PMID: 40016585 DOI: 10.1038/s41423-025-01271-0.


modulation of proinflammatory and proteolytic activities of by selected lactobacilli.

Naja J, Desparois L, Hebert E, Nader M, Saavedra L, Minahk C J Oral Microbiol. 2025; 17(1):2469894.

PMID: 40013015 PMC: 11864006. DOI: 10.1080/20002297.2025.2469894.


References
1.
Thorbert-Mros S, Larsson L, Berglundh T . Cellular composition of long-standing gingivitis and periodontitis lesions. J Periodontal Res. 2014; 50(4):535-43. DOI: 10.1111/jre.12236. View

2.
Salvi G, Lang N . The effects of non-steroidal anti-inflammatory drugs (selective and non-selective) on the treatment of periodontal diseases. Curr Pharm Des. 2005; 11(14):1757-69. DOI: 10.2174/1381612053764878. View

3.
Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S . Identification of a factor that links apoptotic cells to phagocytes. Nature. 2002; 417(6885):182-7. DOI: 10.1038/417182a. View

4.
Ricklin D, Lambris J . Complement in immune and inflammatory disorders: pathophysiological mechanisms. J Immunol. 2013; 190(8):3831-8. PMC: 3623009. DOI: 10.4049/jimmunol.1203487. View

5.
Chen C . COX-2's new role in inflammation. Nat Chem Biol. 2010; 6(6):401-2. DOI: 10.1038/nchembio.375. View